2020
DOI: 10.1016/j.amjcard.2020.07.046
|View full text |Cite
|
Sign up to set email alerts
|

Risk for Recurrent Cardiovascular Events and Expected Risk Reduction With Optimal Treatment 1 Year After an Acute Coronary Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 28 publications
0
4
0
1
Order By: Relevance
“…The terms "SMuRF" and "SMuRF-less" have been coined in 2017 by Vernon et al (6). Patients presenting with ACS without any SMuRFs have been recognized as a significant and separate clinical entity since their proportion has shown increasing trends during the last decades (5,15,16). The prevalence of SMuRF-less status in cardiovascular disease seems to range from 3 to 27% depending on the studied population (2, 5-7, 9, 14, 17-19).…”
Section: Discussionmentioning
confidence: 99%
“…The terms "SMuRF" and "SMuRF-less" have been coined in 2017 by Vernon et al (6). Patients presenting with ACS without any SMuRFs have been recognized as a significant and separate clinical entity since their proportion has shown increasing trends during the last decades (5,15,16). The prevalence of SMuRF-less status in cardiovascular disease seems to range from 3 to 27% depending on the studied population (2, 5-7, 9, 14, 17-19).…”
Section: Discussionmentioning
confidence: 99%
“…Кроме чисто процедурных и анатомических особенностей, риск повторных коронарных событий у пациентов, перенесших ОКС, определяют модифицируемые факторы риска (ФР), такие как уровень систолического артериального давления (АД) и холестерина липопротеидов низкой плотности (ХС-ЛНП), в особенности -их сосуществование. При активном контроле этих факторов 10-летний риск повторных ССО удается снизить до <10% в половине случаев [1].…”
Section: Discussionunclassified
“…In addition to the conventional risk factors, the variables with the highest predictable value determined by XGBoost included prior ASCVD and non-traditional risk factors, like education and socioeconomic levels. Similarly, other ML studies (Reduction of Atherothrombosis for Continued Health and Second Manifestations of Arterial Disease) reported consistent performance throughout the cohort in weeding out residual risk in those with established cardiovascular diseases 2 3. Nevertheless, it is essential to recognise the limitation of these models in younger lower-risk populations without prior ASCVD.…”
mentioning
confidence: 83%